None
Quote | Willow Biosciences (OTCMKTS:CANSD)
Last: | $ |
---|---|
Change Percent: | -3.04% |
Open: | $0.9381 |
Close: | $0.9381 |
High: | $0.9381 |
Low: | $0.9381 |
Volume: | 1,000 |
Last Trade Date Time: | 12/31/1969 07:00:00 pm |
News | Willow Biosciences (OTCMKTS:CANSD)
(NewsDirect) Willow Bioscience CEO Dr Chris Savile joined Steve Darling from Proactive to share a significant development. The company has unveiled a noteworthy partnership with a Nasdaq-listed biopharmaceutical company, with a shared objective of forging precise and efficient manufacturi...
(NewsDirect) Willow Bioscience CEO Dr Chris Savile joined Steve Darling from Proactive to announce a significant collaboration agreement between Willow Biosciences and Suanfarma. The partnership is focused on optimizing cell line productivity for manufacturing a high-volume anti-infec...
Message Board Posts | Willow Biosciences (OTCMKTS:CANSD)
Subject | By | Source | When |
---|---|---|---|
No posts yet. |
News, Short Squeeze, Breakout and More Instantly...
Willow Biosciences Company Name:
CANSD Stock Symbol:
OTCMKTS Market:
(NewsDirect) Willow Bioscience CEO Dr Chris Savile joined Steve Darling from Proactive to share a significant development. The company has unveiled a noteworthy partnership with a Nasdaq-listed biopharmaceutical company, with a shared objective of forging precise and efficient manufacturi...
(NewsDirect) Willow Bioscience CEO Dr Chris Savile joined Steve Darling from Proactive to announce a significant collaboration agreement between Willow Biosciences and Suanfarma. The partnership is focused on optimizing cell line productivity for manufacturing a high-volume anti-infec...
(NewsDirect) Willow Bioscience CEO Dr Chris Savile joined Steve Darling from Proactive to announce some significant developments within the company. Willow Bioscience specializes in the production of ursodeoxycholic acid (UDCA), a vital pharmaceutical ingredient with extensive applica...